Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Grape seed extract is good for skin care, with antioxidant, anti-inflammatory, and anti-cancer effects.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Certain nutrients can help keep skin healthy as we age.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Grateloupia elliptica extract may help prevent hair loss and promote hair growth.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.